International Journal of Cancer

• 

  Publication Venue For

  • Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma..  144:2707-2717. 2019
  • A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants..  144:2192-2205. 2019
  • Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study. 2019
  • Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics. 2019
  • Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival..  144:1867-1876. 2019
  • Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival. 2019
  • Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients. 2019
  • Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients..  144:251-262. 2019
  • BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia..  143:2647-2658. 2018
  • Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age..  143:2359-2366. 2018
  • Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer..  143:2400-2408. 2018
  • Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice.  143:1797-1805. 2018
  • A TGF-β1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer..  143:1327-1334. 2018
  • Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells..  143:921-930. 2018
  • DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions..  143:552-560. 2018
  • Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival..  142:2303-2312. 2018
  • Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk..  142:1322-1331. 2018
  • An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy..  142:1218-1229. 2018
  • Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium..  142:460-469. 2018
  • Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes..  141:2215-2227. 2017
  • Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx..  141:1355-1364. 2017
  • A PGC1β genetic variant associated with nevus count and melanoma mortality..  141:1066-1067. 2017
  • Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer..  141:731-743. 2017
  • Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival..  141:721-730. 2017
  • Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies..  140:2422-2435. 2017
  • BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer..  140:2051-2059. 2017
  • Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology..  140:1447-1456. 2017
  • Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival..  140:1270-1279. 2017
  • Dietary inflammatory index and risk of epithelial ovarian cancer in African American women..  140:535-543. 2017
  • Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: A pooled analysis of prospective studies in China, Japan, and Korea..  140:591-599. 2017
  • Genetic variants of JNK and p38α pathways and risk of non-small cell lung cancer in an Eastern Chinese population..  140:807-817. 2017
  • Lifecourse socioeconomic status and cancer-related risk factors: Analysis of the WHO study on global ageing and adult health (SAGE)..  140:777-787. 2017
  • A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer..  139:2646-2654. 2016
  • Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival..  139:2730-2737. 2016
  • Telomere structure and maintenance gene variants and risk of five cancer types..  139:2655-2670. 2016
  • A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants..  139:2012-2020. 2016
  • A prospective study of dietary patterns and cancer mortality among Blacks and Whites in the REGARDS cohort..  139:2221-2231. 2016
  • Obesity, weight gain, and ovarian cancer risk in African American women.  139:593-600. 2016
  • Obesity, weight gain, and ovarian cancer risk in African American women..  139:593-600. 2016
  • Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients..  138:2592-2601. 2016
  • Screening for familial and hereditary prostate cancer..  138:2579-2591. 2016
  • A quantitative microscopic approach to predict local recurrence based on in vivo intraoperative imaging of sarcoma tumor margins..  137:2403-2412. 2015
  • Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy..  137:2454-2461. 2015
  • Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk..  137:1901-1909. 2015
  • Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma..  137:1679-1690. 2015
  • Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival.  137:638-645. 2015
  • Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival..  137:638-645. 2015
  • A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery..  136:1976-1984. 2015
  • The relationship between blood IL-12p40 level and melanoma progression..  136:1874-1880. 2015
  • Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: a meta-analysis..  136:E751-E759. 2015
  • Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries..  136:1125-1139. 2015
  • Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya..  136:392-398. 2015
  • Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.  136:382-391. 2015
  • TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx..  135:1615-1624. 2014
  • Epigenetic determinants of ovarian clear cell carcinoma biology.  135:585-597. 2014
  • Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy..  134:1907-1915. 2014
  • Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya..  134:740-745. 2014
  • Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries 2014
  • Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis..  133:1765-1775. 2013
  • Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx..  133:695-704. 2013
  • Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors..  132:2339-2348. 2013
  • Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors.  132:2339-2348. 2013
  • Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers 2013
  • Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.  133:2234-2244. 2013
  • Combined p53-related genetic variants together with HPV infection increase oral cancer risk..  131:E251-E258. 2012
  • Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps..  131:512-517. 2012
  • Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.  132:795-806. 2012
  • The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer..  130:20-28. 2012
  • Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls..  129:1932-1939. 2011
  • Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas..  129:111-121. 2011
  • Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer..  128:2063-2074. 2011
  • Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.  128:492-499. 2011
  • Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo..  127:2949-2958. 2010
  • Allergies, obesity, other risk factors and survival from pancreatic cancer..  127:2412-2419. 2010
  • Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo..  126:2893-2903. 2010
  • Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk..  126:2509. 2010
  • Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening.  126:469-473. 2010
  • Chronic cigarette smoke extract treatment selects for apoptotic dysfunction and mitochondrial mutations in minimally transformed oral keratinocytes.  126:19-27. 2010
  • p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck..  125:2660-2665. 2009
  • IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era..  125:680-687. 2009
  • XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study..  124:2948-2953. 2009
  • Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer..  124:2152-2158. 2009
  • Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population..  124:2172-2178. 2009
  • DNA repair phenotype and cancer susceptibility--a mini review..  124:999-1007. 2009
  • Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium..  124:394-401. 2009
  • Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study..  123:1883-1891. 2008
  • Consortium analysis of 7 candidate SNPs for ovarian cancer..  123:380-388. 2008
  • Chromosome 8q24 markers: risk of early-onset and familial prostate cancer..  122:2876-2879. 2008
  • Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study..  122:2077-2084. 2008
  • In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck..  121:2735-2740. 2007
  • Cancer risk in women prenatally exposed to diethylstilbestrol..  121:356-360. 2007
  • Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse..  120:2339-2343. 2007
  • Effects of base excision repair gene polymorphisms on pancreatic cancer survival..  120:1748-1754. 2007
  • Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism..  120:1005-1012. 2007
  • In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer..  120:906-917. 2007
  • DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.  121:1724-1728. 2007
  • Defective antitumor responses in CX3CR1-deficient mice.  121:316-322. 2007
  • Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women..  119:2173-2178. 2006
  • Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients..  119:1455-1461. 2006
  • Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population..  118:2554-2558. 2006
  • Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH..  118:1159-1164. 2006
  • Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population..  118:1275-1278. 2006
  • Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs)..  116:487-491. 2005
  • DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population..  115:478-483. 2005
  • Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis..  115:131-136. 2005
  • Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population..  114:455-460. 2005
  • Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer.  113:1022-1025. 2005
  • Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers..  112:754-759. 2004
  • Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum.  112:135-142. 2004
  • Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice.  111:475-479. 2004
  • Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice..  111:475-479. 2004
  • NF-κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells.  108:181-188. 2004
  • Smoking, DNA repair capacity and risk of nonsmall cell lung cancer..  107:84-88. 2003
  • The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice..  103:300-305. 2003
  • Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma..  102:338-342. 2002
  • Prevalence of human papillomavirus in cervical cancer: A multicenter study in China.  100:327-331. 2002
  • A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis..  99:869-872. 2002
  • Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma..  98:419-426. 2002
  • Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era..  96:363-371. 2001
  • Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancer..  94:834-841. 2001
  • Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case-control study.  95:332-336. 2001
  • Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study..  95:332-336. 2001
  • Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization..  96:243-252. 2001
  • In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck..  93:436-440. 2001
  • Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness..  93:236-242. 2001
  • Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes..  92:322-328. 2001
  • Non-human to human organ transplantation: its biologic basis and a potential role for radiation therapy..  96:76-89. 2001
  • Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier..  91:334-339. 2001
  • Clinical staging of prostate cancer: Reproducibility and clarification of issues.  96:198-209. 2001
  • Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas..  95:34-38. 2001
  • Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer.  95:29-33. 2001
  • Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions..  88:766-771. 2000
  • Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv..  88:962-969. 2000
  • In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215..  88:652-657. 2000
  • Polymorphisms of the DNA repair geneXRCC1 and risk of gastric cancer in a Chinese population.  88:601-606. 2000
  • Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population..  88:601-606. 2000
  • Review of methods used to study oxygen transport at the microcirculatory level..  90:237-255. 2000
  • p53-dependent induction of heat shock protein 27 (HSP27) expression..  88:191-194. 2000
  • Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes..  86:818-826. 2000
  • ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers..  86:690-694. 2000
  • p53-Dependent induction of heat shock protein 27 (hsp27) expression.  88:191-194. 2000
  • Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity..  83:532-540. 1999
  • Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238..  82:592-598. 1999
  • Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA..  82:121-124. 1999
  • Allelic loss on chromosome 6Q in primary prostate cancer..  84:331-335. 1999
  • Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck.  84:220-224. 1999
  • Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck..  84:220-224. 1999
  • Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.  78:46-52. 1998
  • Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase..  78:46-52. 1998
  • IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential..  77:138-145. 1998
  • Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector..  71:377-382. 1997
  • Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts..  70:706-715. 1997
  • Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.  67:898-902. 1996
  • Radio-induced modulation of transforming growth factor β1 sensitivity in ap53 wild-type human colorectal-cancer cell line.  68:126-131. 1996
  • Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin..  67:695-701. 1996
  • Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA..  67:898-902. 1996
  • Radio-induced modulation of transforming growth factor beta1 sensitivity in a p53 wild-type human colorectal-cancer cell line..  68:126-131. 1996
  • CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines..  63:226-230. 1995
  • TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract..  64:229-233. 1995
  • Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies..  58:161-167. 1994
  • Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent..  57:908-913. 1994
  • Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma..  56:552-559. 1994
  • Induction of tissue-type plasminogen activator and 72-kDa type-IV collagenase by ionizing radiation in rat astrocytes..  56:214-218. 1994
  • Meta-[²¹¹ At]astatobenzylguanidine: Further evaluation of a potential therapeutic agent.  57:908-913. 1994
  • Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells..  53:409-417. 1993
  • Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185..  53:401-408. 1993
  • Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma..  52:934-940. 1992
  • Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.  52:682-687. 1992
  • Effect of IL-1 on experimental bone/bone-marrow metastases..  52:802-807. 1992
  • Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity..  52:609-618. 1992
  • Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugates..  52:38-43. 1992
  • A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines..  51:772-779. 1992
  • Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction..  50:694-701. 1992
  • Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines..  50:659-664. 1992
  • Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid..  46:238-244. 1990
  • Polyamine-directed preferential nutritional repletion of normal tissues in tumor-bearing hosts..  42:744-747. 1988
  • The relationship of collagenolytic activity to stage of human colorectal carcinoma..  40:24-31. 1987
  • EL-4 metastases in spleen and bone marrow suppress the NK activity generated in these organs..  39:118-125. 1987
  • The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA..  39:25-29. 1987
  • Red blood cell polyamine levels and host toxicity during continuous alpha-difluoromethylornithine infusion..  38:245-249. 1986
  • Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: a prospective study..  33:777-782. 1984
  • Metabolism of benzo[a]pyrene by cultured tracheobronchial tissues from mice, rats, hamsters, bovines and humans..  25:293-300. 1980
  • Isolation of a human prostate carcinoma cell line (DU 145)..  21:274-281. 1978
  • Ribosomal RNA in avian leukosis virus particles..  7:535-546. 1971
  • Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238.  82:592-598.
  • IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas (International Journal of Cancer (2009) 125, (2673-2678)).  126:799. 2010